- Home
- JRVR vs AMRN Comparison
JRVR vs AMRN Comparison
Compare JRVR & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRVR
- AMRN
- Stock Information
- Founded
- JRVR 2002
- AMRN 1989
- Country
- JRVR Bermuda
- AMRN Ireland
- Employees
- JRVR N/A
- AMRN N/A
- Industry
- JRVR Property-Casualty Insurers
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- JRVR Finance
- AMRN Health Care
- Exchange
- JRVR Nasdaq
- AMRN Nasdaq
- Market Cap
- JRVR 241.0M
- AMRN 234.4M
- IPO Year
- JRVR 2005
- AMRN 1993
- Fundamental
- Price
- JRVR $6.59
- AMRN $0.61
- Analyst Decision
- JRVR Buy
- AMRN Hold
- Analyst Count
- JRVR 6
- AMRN 3
- Target Price
- JRVR $11.17
- AMRN $1.00
- AVG Volume (30 Days)
- JRVR 224.3K
- AMRN 629.3K
- Earning Date
- JRVR 11-05-2024
- AMRN 10-30-2024
- Dividend Yield
- JRVR 3.08%
- AMRN N/A
- EPS Growth
- JRVR N/A
- AMRN N/A
- EPS
- JRVR N/A
- AMRN N/A
- Revenue
- JRVR $815,639,000.00
- AMRN $264,779,000.00
- Revenue This Year
- JRVR N/A
- AMRN N/A
- Revenue Next Year
- JRVR $8.37
- AMRN N/A
- P/E Ratio
- JRVR N/A
- AMRN N/A
- Revenue Growth
- JRVR 23.89
- AMRN N/A
- 52 Week Low
- JRVR $6.12
- AMRN $0.56
- 52 Week High
- JRVR $15.47
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- JRVR 49.30
- AMRN 49.61
- Support Level
- JRVR $6.12
- AMRN $0.56
- Resistance Level
- JRVR $6.49
- AMRN $0.59
- Average True Range (ATR)
- JRVR 0.22
- AMRN 0.03
- MACD
- JRVR 0.04
- AMRN 0.00
- Stochastic Oscillator
- JRVR 69.12
- AMRN 50.89
About JRVR James River Group Holdings Ltd.
James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure. and the Corporate and other segment consists of the management and treasury activities of holding companies, equity compensation for the group.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.